COVID-19 in Scottish patients receiving renal replacement therapy

  • Public Health Scotland
  • 10 Jun 2020

  • curated by Pavankumar Kamat
  • UK Medical News
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Public Health Scotland has published data from the Scottish Renal Registry (SRR) pertaining to patients with end-stage renal disease (ESRD) receiving renal replacement therapy (RRT) who have tested positive for COVID-19. The SSR is a national registry of all Scottish patients receiving RRT, including haemodialysis, peritoneal dialysis and transplants.

Patients receiving dialysis or kidney transplant recipients are considered a vulnerable population. Patients undergoing dialysis typically tend to be older and have other comorbidities. Such patients often need to visit a health care facility on a regular basis, which further heightens their risk of exposure to SARS-CoV-2.

Key findings from the report as of 31 May 2020 are as follows:

  • Between 1 March 2020 and 31 May 2020, 110 patients receiving RRT in Scotland tested positive for COVID-19. This figure corresponds to 2 per cent of the total RRT population in Scotland.
  • Positive COVID-19 tests among patients receiving RRT peaked between the week beginning 30 March 2020 and 6 April 2020.
  • Patients undergoing haemodialysis, individuals aged 44-74 years and those residing in more socially deprived areas accounted for the highest number of positive COVID-19 tests
  • As of 31 May 2020, 28.2 per cent of patients on RRT who tested positive for COVID-19 had died.
  • The survival rate at 30 days following the first positive COVID-19 test was estimated to be 78 per cent.